Experience

ADRES Int'l Biotech Consultation & Execution

• Israel
• Biotechnology Research
• 1 - 100 Employee

• Scientific & Regulatory Affairs Director

  • Jun 2020 - Present



OPKO Biologics Ltd.

• Israel
• Biotechnology
• 1 - 100 Employee

• Associate Director, Pharmacology and Toxicology

  • Apr 2018 - Jun 2020

• Scientific Leader, Pharmacology and Toxicology

  • Jun 2016 - Apr 2018

  Responsible for the development of new potential therapeutics and supporting them through the clinical stage.

• Principle Scientist, Preclinical and Clinical Pharmacology

  • Sep 2013 - Jun 2016

  Plan and management of Pharmacology and Toxicology studies at CROsADME research and evaluationDevelopment, qualification and Validation of bio-analytical methods (ELISA, CBA and LC-MS/MS), in house or outsource.GxP lab working and analysisData analysis, writing and review reports and scientific documentation

• Reaserch Associate, R&D Department

  • May 2011 - Sep 2013

  Supporting Proof Of Concept in-vitro and in-vivo studiesDevelopment and Qualification of Bio-analysis methods for product characterizationDevelopment and Qualification of ELISA methods for product quantitation in human and animal matrixSupporting protein purification process by quantitative and potency methods



D-Pharm

• Israel

• Research Associate

  • Jan 2008 - Apr 2011

  Research Associate in the Cellular Biochemistry Laboratory at D-Pharm innovative biopharmaceuticals. Participation in the following researches: 1. Neuroprotective Compound Research: Screening and selection of compounds with neuroprotective potential. In depth examination of the mechanism of action of the leading compound which is in advanced clinical trial. 2. Ostersarcoma Compounds Research: Screening and mechanism of potential therapeutic compounds for Osteosarcoma treatment. Research Associate in the Cellular Biochemistry Laboratory at D-Pharm innovative biopharmaceuticals. Participation in the following researches: 1. Neuroprotective Compound Research: Screening and selection of compounds with neuroprotective potential. In depth examination of the mechanism of action of the leading compound which is in advanced clinical trial. 2. Ostersarcoma Compounds Research: Screening and mechanism of potential therapeutic compounds for Osteosarcoma treatment.